← Back to Patent Explorer
US4591564A Expired / Lapsed US ⏱️ 0.0 years remaining

Transferase enzymes which modify the 3'-termini of ribonucleic acid and methods

Assignee: University of Montana – Missoula
•
Filing: 1982-11-10
•
Granted: 1986-05-27
•
Expires: 2002-11-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Three ribonucleotidyl terminal transferase enzymes are disclosed which modify the 3'-termini of ribonucleic acid (RNA) molecules by the addition of ribonucleotide units using ribonucleoside triphosphates as substrates. These terminal transferase activities are distinguishable by the specific ribonucleotide (e.g. AMP, CMP, or UMP) transferred to the 3'-hydroxyl terminus of an RNA primer. Also provided is a method for the 3'-terminal modification of RNA molecules by these enzymes and sequencing of RNA from its 3'-termini. The methods provide a convenient and efficient procedure for 3'-terminal modification (homopolymer tailing) of RNA required for synthesis of complete complementary DNA (cDNA) copies or double-stranded DNA gene copies by retrovirus-associated reverse transcriptase. Using the enzymes of the invention, RNA can also be radiolabelled to very high levels for molecular hybridization.

Inventors

  • 👤 Kenneth F. Watson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 22:44
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/10; C12N9/12; C12N9/1241; C12N9/1258; C12N15/00; C12N15/09; C12N15/10; C12P; C12P19/00; C12P19/26; C12P19/28; C12P19/30; C12P19/34

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 94 words
A method for the isolation of three ribonucleotidyl terminal transferase enzymes, said enzymes having the capability of modifying the 3' terminus of ribonucleic acid molecules by the addition of ribonucleotide units using ribonucleotide triphosphates as substrates, said method comprising: (a) injecting of chicks with avian myeloblastosis virus so that the chicks develop acute leukemia characterized by a high percentage of myeloblasts in the peripheral blood; (b) removing the blood and isolating the myeloblasts; (c) eliminating the myeloblasts' nuclei; (d) separating and fractionating proteins; (f) determining enzyme activity, and (g) recovering the terminal transferase enzymes.
Claim 2
Independent Claim 94 words
A method for the isolation of three ribonucleotidyl terminal transferase enzymes, said enzymes having the capability of modifying the 3' terminus of ribonucleic acid molecules by the addition of ribonucleotide units using ribonucleotide triphosphates as substrates, said method comprising: (a) injecting of chicks with avian myeloblastosis virus so that the chicks develop acute leukemia characterized by a high percentage of myeloblasts in the peripheral blood; (b) removing the blood and isolating the myeloblasts; (c) eliminating the myeloblasts' nuclei; (d) separating and fractionating proteins; (f) determining enzyme activity, and (g) recovering the terminal transferase enzymes.
Claim 3
Dependent Claim 125 words
A method according to claim 1 comprising the steps of: (a) inoculation of chicks with avain myeloblastosis virus so that the chicks develop acute leukemia characterized by a high percentage of myeloblasts in the peripheral blood; (b) removal of the blood and separation of the myeloblasts by centrifugation and washing; (c) sedimentation of the nuclei of the separated myeloblasts by homogenization or sonication and centrifugation; (d) treatment of the supernatant by a protamine precipitation or DEAE-cellulose chromatography to remove soluble nucleic acids; (e) separation of proteins by cation exchange chromatographies; (f) radioactive assay of column fractions to determine ribonucleotidyl terminal transferase activity; (g) further separation and purification of the fractions by precipitation, centrifugation, resuspension, and velocity gradient centrifugation; and (h) recovering the terminal transferase enzymes.
Claim 4
Dependent Claim 22 words
A method according to claim 1 wherein the enzyme modifies the 3' terminus of ribonucleic acid with the transfer of uridine-5' monophosphate.
Claim 5
Dependent Claim 21 words
A method according to claim 1 wherein the enzyme modifies the 3' terminus of ribonucleic acid with the transfer of cytidine-5'-monophosphate.
Claim 6
Dependent Claim 21 words
A method according to claim 1 wherein the enzyme modifies the 3' terminus of ribonucleic acid with the transfer of adenosine-5'-monophosphate.

References Cited (Backward Citations)

US3594278A Cited
US3779867A Cited
US3796631A Cited
US3850749A Cited
US3849249A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-05-26 1989-11-25 1990-05-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-05-26 1993-11-25 1994-05-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-05-26 1997-11-25 1998-05-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag